Explore Charcot disease in the foot—how peripheral neuropathy leads to progressive joint degeneration, with the tarsometatarsal and metatarsophalangeal joints most commonly affected. Learn why these weight-bearing joints are especially vulnerable and how numbness alters mechanical stress patterns.

Multiple Choice

Which two joints are most often affected by Charcot disease?

In Charcot disease, which is a progressive condition characterized by the degeneration of bones and joints, the most commonly affected joints are indeed the tarsometatarsal and metatarsophalangeal joints. This condition is often seen in individuals with peripheral neuropathy, where loss of sensation leads to undetected trauma and subsequent joint damage. The tarsometatarsal joints, located between the tarsal bones and the metatarsal bones, are particularly vulnerable due to their role in weight-bearing and the mechanical stress they endure during movement. Similarly, the metatarsophalangeal joints, which connect the metatarsals to the proximal phalanges of the toes, are also subjected to significant forces during walking and standing. This combination of high mechanical stress and lack of proprioceptive feedback in Charcot disease patients contributes to the rapid degeneration of these joints. The other joints listed, while they may be involved in different types of joint diseases or conditions, are not characteristic of Charcot disease in the same way the tarsometatarsal and metatarsophalangeal joints are.

Charcot neuroarthropathy is one of those conditions that sits at the crossroads of neurology, orthopedics, and rehab engineering. It’s not flashy, but it’s stubborn and consequential. For students stepping into the world of orthotics and prosthetics, understanding where Charcot often hits—the feet—helps translate theory into thoughtful, practical care. And the feet, in particular, aren’t just “the ends” of our legs. They’re complex, load-bearing ecosystems that tell a story about sensation, structure, and how we move through daily life.

Why the feet become the stage for Charcot

Charcot disease—more formally Charcot neuroarthropathy—unfolds most visibly in people with peripheral neuropathy. When sensation in the feet deteriorates, trauma can occur without the person noticing. Tiny fractures, repetitive stress, and micro-instability set off a cascade: bone resorption, deformity, and soft tissue breakdown. The result isn’t just a crooked toe or a swollen ankle; it’s a foot that behaves unpredictably under pressure, which, in turn, creates more trauma. It’s a feedback loop that orthotics and prosthetics care providers learn to interrupt.

Now, the two joints that tend to bear the brunt are the tarsometatarsal joints (the joints between the long bones of the foot and the bones of the midfoot) and the metatarsophalangeal joints (where the metatarsals meet the toe bones). Think of the tarsometatarsal joints as the major connectors in the midfoot, a fulcrum point for how the foot flexes and adapts when you roll from heel to toe. The metatarsophalangeal joints are the pivot points at the ball of the foot, where propulsion begins during push-off. Both are critical for weight transfer and balance during gait.

Why these joints, specifically? It’s about load, motion, and sensory feedback. The midfoot (including the tarsometatarsals) is a structural hub—rigid enough to support the arch yet flexible enough to accommodate terrain. The MTP joints, meanwhile, endure substantial bending and loading with every step, especially during propulsion. In a neuropathic foot, any abnormal motion or unrecognized microtrauma at these joints compounds the risk of rapid, progressive damage. In short: those joints are workhorses, and when sensation is muted, a small problem can become a big problem fast.

What this means for care teams in orthotics and prosthetics

If you’re on the care side, the goal is to preserve structure, protect tissue, and restore as much function as possible without compromising the joint’s stability. It’s a careful balance between immobilization to quiet inflammation and controlled mechanical support to prevent further insult.

  • Early recognition and monitoring: Charcot can start silently. Patients might report warmth, swelling, or redness, but they may not feel pain the way they used to. Regular foot checks, temperature comparisons between feet, and a low threshold for imaging when changes arise are essential. The emphasis isn’t just on treating a present deformity but on preventing a worse one.

  • Immobilization strategies: In the active phase, stability is paramount. Total contact casts (TCCs) or protected walking boots are common to offload and stabilize the affected joints. The idea is simple: reduce micro-movements, dampen mechanical stress, and give the bones a chance to heal or stabilize. The exact duration varies, but the principle remains consistent: immobilize enough to protect the vulnerable joints, while keeping the patient engaged with care plans.

  • Offloading and footwear: Once the acute phase broadens toward stabilization, the emphasis shifts to offloading specific joints and redistributing pressure. Custom orthotics, specialty footwear, and selective wedging can help shift load away from the tarsometatarsal and metatarsophalangeal joints without rigidly locking out mobility. From a practical standpoint, you want footwear that accommodates the foot’s evolving shape while maintaining a stable base of support.

  • Orthotic device design: The design choices aren’t random. They’re guided by foot mechanics, stage of Charcot, and the patient’s daily activities. An orthotic that’s too rigid can create pressure points elsewhere; one that’s too soft won’t shield the joints adequately. The right device often blends soft, protective materials with strategic posting, a supportive arch, and a sole that offers proprioceptive cues without encouraging excessive motion at the vulnerable joints.

  • Proprioception and nerve health: Even with a well-fitted orthosis, sensory feedback remains compromised. Education plays a big role here. Patients learn to inspect their feet daily, to watch for signs of pressure hotspots, color changes, or new swelling. The care team reinforces safe ambulation habits and footwear maintenance. It’s not just about the device—it’s about the ongoing partnership to protect the foot’s integrity.

  • Tissue preservation and skin care: Deformity often goes hand in hand with skin vulnerability. Ulcers can form where misfit pressure concentrates. Regular skin checks, barrier creams for dry skin, and promptly addressing any breakdowns are part of the routine. In many cases, orthotics teams coordinate with wound care to keep potential trouble spots under control.

The bigger picture: movement, function, and quality of life

Charcot isn’t only about bones and joints. It affects how people stand, walk, and participate in daily activities. A foot that’s stable and well-supported can open doors—literally—to better balance, safer ambulation on varied surfaces, and reduced fear of stumbling. Conversely, without thoughtful support, the cycle of pain, deformity, and reduced mobility can become a self-fulfilling prophecy: less activity, weaker muscles, more weight on the nonaffected side, and further imbalance.

That’s why a holistic approach matters. Orthotics and prosthetics professionals aren’t just fitting a shoe or a brace; they’re engineering a pathway for safer gait, longer-lasting feet, and a life that doesn’t revolve around pain or caution. The two joints at the heart of Charcot in the foot aren’t isolated islands. They’re integral to how the entire kinetic chain functions—from leg mechanics to hip stability to even posture in daily tasks.

A few practical reminders for students and practitioners

  • Start with the anatomy, then the function: Understanding the load-bearing roles of the tarsometatarsal joints and the MTP joints helps you predict where deformities will flare and where to distribute forces.

  • Early stabilization pays dividends: If you see signs of Charcot activity, the priority is to minimize motion at the suspect joints. Immobilization isn’t a step back; it’s a strategic step forward toward long-term stability.

  • Customization beats off-the-shelf solutions: No two Charcot feet are identical. The most effective devices account for the person’s unique gait patterns, bone structure, and daily routines. It’s a collaboration among patient, physician, and orthotics team.

  • Real-world wear matters: Education around footwear inspection and maintenance isn’t optional. Small care routines—checking for pressure points after a long day, switching to moisture-wicking socks, or rotating footwear for even wear—can prevent complications.

  • Keep the long view in sight: The path from swelling to stability can span weeks or months, sometimes longer. Patience, consistent follow-up, and willingness to adjust the device as the foot evolves are part of the work.

A little digression that helps anchor the idea

If you’ve ever watched a city landscape adapt to weather—think of a bridge slowly tightening after a storm—you’ll get a sense of Charcot management. The foot is a living system that responds to load, sensation, and tissue resilience. When nerves fail to give timely feedback, engineers (that’s you, with your orthotic toolkit) step in to compensate. It’s not about overpowering the body; it’s about honoring what the body can do safely and supporting it as it finds its balance again. And like any engineering project, the best outcomes come from attention to detail, thoughtful materials, and a plan that flexes with reality.

What to take away for practice and study

  • The tarsometatarsal and metatarsophalangeal joints are the usual suspects in Charcot-related deformities of the foot because they bear heavy loads and require precise control for stable propulsion.

  • An effective approach blends immobilization during active phases with well-chosen offloading and supportive footwear as the process stabilizes. The aim is to protect vulnerable joints while enabling meaningful activity.

  • The orthotics you design should be a dynamic tool—adjusted as the foot changes, as the patient’s activities evolve, and as tissue tolerance shifts. Rigid is not inherently bad, but rigidity without room to breathe—in the right places—can backfire.

  • Education and routine care are as vital as the hardware. A device that sits on the shelf but isn’t used or isn’t adjusted is less useful than a thoughtful, patient-centered plan that speaks to daily life.

To wrap it up, Charcot disease in the foot is less about a single wrong move and more about a cascade that starts with sensory loss, then compounds with mechanical stress. The tarsometatarsal and metatarsophalangeal joints often bear the brunt because they’re central to how weight moves through the foot. For students stepping into orthotics and prosthetics, this is a reminder: great care blends science with empathy, engineering with practicality, and a steady hand with a patient’s everyday life. The right support can keep people not just standing, but stepping forward with confidence, one measured step at a time.